MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis

BACKGROUND AND PURPOSE: Myeloid differentiation 2 (MD-2) recognizes LPS, which is required for TLR4 activation, and represents an attractive therapeutic target for severe inflammatory disorders. We previously found that a chalcone derivative, L6H21, could inhibit LPS-induced overexpression of TNF-α...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: Wang, Yi, Shan, Xiaoou, Chen, Gaozhi, Jiang, Lili, Wang, Zhe, Fang, Qilu, Liu, Xing, Wang, Jingying, Zhang, Yali, Wu, Wencan, Liang, Guang
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4556476/
https://ncbi.nlm.nih.gov/pubmed/26076332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13221
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados